Ebola Outbreak 2026: How Disease Control Measures Are Responding

Last updated: May 25, 2026. This is a rapidly evolving situation. All figures reflect the most recent verified data available at time of publication. Readers are encouraged to consult the WHO Ebola situation page and the CDC Ebola current situation page for the latest updates.

A new and deeply serious Ebola outbreak is unfolding in Central and East Africa. On May 15, 2026, the Ministry of Health of the Democratic Republic of the Congo (DRC) officially confirmed an outbreak of Ebola disease in Ituri Province in northeastern DRC. Two days later, on May 17, the World Health Organization declared the situation a Public Health Emergency of International Concern - its highest formal alert level - triggering a rapid mobilization of international resources that is still actively expanding.

This is the 17th recorded Ebola outbreak in the DRC since the virus was first identified in 1976, and it comes just five months after the end of the previous outbreak. But several features make it critically different from those that came before - and significantly harder to control.

As of May 24, 2026, the DRC and Uganda Ministries of Health report nearly 1,000 suspected cases and at least 216 deaths, with confirmed spread across multiple provinces in DRC, and imported cases in Uganda's capital Kampala. The true scale of the outbreak is likely considerably larger than the confirmed case count suggests.

What Makes This Ebola Outbreak Different

The Bundibugyo Virus - A Rare and Uncharted Pathogen

The single factor that most distinguishes this outbreak from all previous Ebola responses is the causative agent. This epidemic is caused by the Bundibugyo virus (Orthoebolavirus bundibugyoense) - one of the rarest and least understood species of Ebola virus known to science.

Bundibugyo virus was first identified in 2007 following an outbreak in the Bundibugyo District of western Uganda, on the border with the DRC. A second outbreak occurred in DRC's Province Orientale in 2012, with 59 cases and 34 deaths. This 2026 event is only the third time in recorded history that this virus has caused a documented human outbreak. The case fatality rate in previous Bundibugyo outbreaks ranged between 30% and 50%.

What makes it so challenging is simple and stark: there are no licensed vaccines and no approved treatments for Bundibugyo virus disease. The two approved Ebola vaccines - Ervebo (rVSV-ZEBOV) from Merck and the Johnson and Johnson vaccine - both target the Zaire ebolavirus, the strain responsible for the majority of previous outbreaks, including the devastating 2014 to 2016 West Africa epidemic. Animal studies indicate these vaccines do not provide good protection against Bundibugyo. Similarly, the two monoclonal antibody treatments approved following clinical trials in DRC between 2018 and 2020 are also specific to the Zaire species and are not indicated here.

As MSF medical lead for epidemic response John Johnson stated, "What makes this outbreak different and significantly harder to fight is the type of virus." In the absence of specific vaccines or treatments, the entire response must rely on foundational public health measures: early case detection, isolation, contact tracing, safe burials, infection prevention and control, and community engagement - the same tools that were used to fight Ebola before any vaccines existed.

The Bundibugyo Virus: Key Facts

Bundibugyo is one of six known species of Orthoebolavirus, four of which cause disease in humans: ebolavirus (Zaire), Sudan virus, Tai Forest virus, and Bundibugyo. Like other Ebola viruses, it is a zoonotic disease, with fruit bats thought to be the natural reservoir, though this has not been confirmed for this species. Transmission to humans is believed to occur through contact with infected animals, carcasses, or bushmeat - and human-to-human transmission occurs through close contact with the blood, secretions, or other bodily fluids of infected individuals.

Early symptoms - fever, headache, sore throat, muscle pain - are difficult to distinguish from many other illnesses, creating diagnostic delays that allow transmission to occur before isolation. Confirming an Ebola diagnosis requires specialized laboratory tests, which are not readily available in the remote and resource-limited settings where this outbreak began.

The Outbreak: Timeline and Geographic Spread

Origins and Early Detection Failures

The origins of this outbreak illustrate how rapidly Ebola can propagate before detection. The earliest known suspected case - a man in Ituri who began experiencing symptoms on April 24, 2026 - died three days later. However, on May 23, the Red Cross revealed that three workers who died between May 5 and May 16 are believed to have contracted Ebola as early as March 27, during dead body management activities in Mongwalu - well before the outbreak was officially identified.

On May 5, WHO received an alert about an unknown illness with high mortality in Mongbwalu Health Zone, Ituri Province, including four health workers who died within four days. Investigation confirmed Bundibugyo virus disease on May 15. Critically, early testing failed to detect the outbreak because standard field diagnostic panels tested only for the Zaire strain - Bundibugyo-specific assays were not included, meaning multiple contacts became symptomatic and died before they could be isolated.

Rapid Geographic Expansion

From Ituri, the outbreak spread with alarming speed. By May 18, WHO reported 516 suspected cases and 131 deaths in DRC across multiple provinces, including cases identified in Butembo in North Kivu Province - a city that was the epicenter of the devastating 2018 to 2020 Kivu Ebola epidemic. A confirmed case was also reported in South Kivu Province.

Across the border in Uganda, two laboratory-confirmed cases were identified in Kampala within 24 hours of each other on May 15 and 16, among individuals who had traveled from DRC. One of those cases died. As of May 24, Uganda had confirmed 12 cases, including healthcare workers and returned travelers. The Africa Centers for Disease Control warned that 10 other African countries are at risk from spread.

One American citizen was exposed to the virus in a healthcare setting in DRC. That person, along with six high-risk contacts, was medically evacuated to a specialized isolation facility in Germany - no confirmed Ebola cases related to this outbreak have been reported in the United States.

The Scale of Underreporting

Health authorities and independent experts are in agreement that the reported case count significantly understates the true scope of the outbreak. WHO's DRC representative noted "significant uncertainty" about how far the virus has spread. Contact tracing in Ituri is being conducted under conditions of active armed conflict, intermittent road closures, and deep community mistrust - and several listed contacts have died before they could be isolated, indicating that transmission chains are longer and more complex than official numbers suggest.

The Five Compounding Challenges Facing Responders

1. No Vaccine, No Approved Treatment

As established, the absence of any licensed vaccine or approved therapeutic for Bundibugyo virus is the defining clinical challenge of this response. In the absence of targeted medical tools, care relies primarily on symptom management and intensive supportive therapy - fluid replacement, oxygen support, fever management, and close monitoring of blood and cardiac parameters. Early supportive care improves survival odds, but it is not a substitute for targeted treatment.

A major vaccine research program is now underway with international partners, and WHO and partners are preparing clinical trials for experimental treatments and potential vaccines targeting the Bundibugyo strain. Several experimental antiviral candidates and monoclonal antibodies do exist in early development phases, though their efficacy has not yet been established in humans. Dr. Paul Offit, director of the Children's Hospital of Philadelphia's Vaccine Education Center, noted that a handful of experimental vaccines are in early development across the globe, but none have reached human trials.

MSF has stated it is ready to contribute to research trials, as it did during the 2019 DRC trials that eventually led to the approval of two vaccines and two treatments for Zaire Ebola.

2. Active Armed Conflict and Mass Displacement

The geographic epicenter of this outbreak - Ituri Province and North Kivu in northeastern DRC - is one of the most conflict-affected regions in the world. Conflict has intensified since late 2025, with fighting escalating significantly over the past two months and over 100,000 people newly displaced in the first quarter of 2026 alone. Nearly one million people are displaced across Ituri Province, many living in overcrowded camps with minimal sanitation and almost no access to healthcare.

Approximately 100 armed groups are fighting for control of different areas across eastern DRC, making it extremely difficult to establish consistent surveillance, deploy response teams, or maintain safe treatment centers. On May 21, a severe security incident occurred in Ituri in which medical tents and supplies were set on fire at the Rwampara General Hospital treatment center. WHO Director-General Dr. Tedros Adhanom Ghebreyesus confirmed that the incident "significantly jeopardized" response operations. Confirmed cases have also been recorded in North Kivu and South Kivu provinces, large areas of which are governed by Rwanda-backed M23 rebels, further complicating access.

As Mercy Corps Country Director for DRC Rose Tchwenko noted: "The speed at which this Ebola outbreak is spreading is deeply worrying. Delays in detecting the earliest case may have allowed the virus to move ahead of the response."

3. Misinformation, Community Distrust, and Cultural Practices

Beyond the security environment, deep community distrust and widespread health misinformation are actively undermining containment efforts. Residents of Ituri and North Kivu - the two most heavily impacted provinces - report that many community members doubt the disease is real. Some have attacked health clinics and treatment centers, refusing to allow health workers to operate in their communities.

A community mobilizer in Bunia told CNN that a local funeral practice involving mourners touching the body of the deceased may have contributed to rising infections. Bodies of Ebola victims are highly infectious, and traditional burial practices that involve close physical contact represent one of the highest-risk transmission events during any Ebola outbreak. Health officials have warned that such practices can rapidly amplify spread and that negotiating with communities around safe burial protocols is one of the most sensitive and critical elements of any response.

As WHO's Director-General acknowledged: "Building trust in the affected communities is critical to a successful response, and is one of our highest priorities."

4. Humanitarian Crisis and Collapsed Health Infrastructure

The outbreak is unfolding against a backdrop of catastrophic pre-existing humanitarian need. Approximately 26.5 million people in DRC are expected to face high levels of acute food insecurity between January and June 2026, including more than 3.6 million people in emergency conditions. Eastern DRC has historically underfunded healthcare infrastructure, and the region has poor road networks that severely limit logistics.

Compounding this, humanitarian assistance flowing into Congo in 2026 is significantly reduced compared to prior years, with aid cuts affecting staffing, supplies, and community health worker coverage. Save the Children's DRC country director Greg Ramm reported a shortage of disinfectant and personal protective equipment, including masks and gowns. In Bunia, the largest city in Ituri, isolation facilities for suspected cases were reported to be at capacity, forcing health teams to convert a surgical center into an improvised isolation unit.

5. Cross-Border Geography and Population Movement

Ituri is a commercial and migration hub with borders shared with Uganda and South Sudan. The region sees heavy movement of people for trade, mining work, and displacement-driven migration. The virus crossed into Uganda within days of the outbreak's detection, and WHO has confirmed that cross-border spread represents a significant ongoing risk, particularly to neighboring countries including Rwanda, Burundi, and South Sudan. The economy of eastern Congo is deeply interconnected with those of neighboring states, making movement restrictions both logistically and economically challenging.

Uganda, notably, postponed its annual Martyrs' Day celebrations - which can attract up to two million people - at the direct request of WHO's Director-General, in recognition of the mass-gathering transmission risk.

How the International Community Is Responding

WHO: Declaring PHEIC and Coordinating the Multilateral Response

On May 17, 2026, WHO Director-General Dr. Tedros Adhanom Ghebreyesus determined that the Bundibugyo virus epidemic in DRC and Uganda constitutes a Public Health Emergency of International Concern under the International Health Regulations (IHR). This declaration - WHO's highest formal alert - activates binding obligations on member states and triggers coordinated international resource mobilization.

WHO has deployed teams, supplies, equipment, and funding to support national authorities across every pillar of the response: contact tracing, treatment center establishment, risk communication, community engagement, laboratory confirmation, infection prevention and control assessments, cross-border preparedness, and surveillance strengthening. WHO has released $3.9 million from its Contingency Fund for Emergencies and, together with Africa CDC, has established a continental Incident Management Support Team.

Response measures include the deployment of 22 international staff, delivery of emergency medical supplies by MONUSCO airlift (nearly 30 tons, including medicines, tents, and protective equipment), and preparation of a multi-agency Strategic Preparedness and Response Plan aligned with the national plans of both DRC and Uganda.

The United States Response: Funding, Clinics, and Deployment

The United States government has moved rapidly and at scale. The US State Department, in close coordination with CDC as the lead US Government agency, mobilized an initial $23 million in bilateral foreign assistance within the first days of the outbreak, supporting surveillance, laboratory capacity, risk communication, safe burials, entry and exit screening, and clinical case management.

The United States then announced a commitment to fund up to 50 treatment clinics in Ebola-affected regions of the DRC and Uganda - rapidly deployed facilities providing emergency Ebola screening, triage, and isolation capacity to establish clinical care and containment perimeters around affected areas. As of May 23, total US bilateral assistance had reached $32 million, channeled through partners including International Medical Corps, UNICEF, MedAir, the International Organization for Migration, the World Food Programme, FHI 360, and Samaritan's Purse.

An initial 50 tons of critical medical supplies were delivered to affected areas, with an additional 100 tons of supplies en route.

A Disaster Assistance Response Team (DART) was mobilized and deployed within four days of the first case notification - described as the fastest-ever DART deployment for a US Ebola response. CDC surged 20 trained disease detectives to the outbreak zone through funding partners, and 23 CDC-trained field epidemiologists are supporting response operations in Uganda. An additional seven headquarters-based viral hemorrhagic fever subject matter experts are being prepared for deployment.

On May 18, CDC and the Department of Homeland Security announced enhanced travel screening, entry restrictions, and public health measures to prevent Ebola from entering the United States.

The UN System: $60 Million and Emergency Coordination

UN Emergency Relief Coordinator Tom Fletcher allocated up to $60 million from the Organization's Central Emergency Response Fund to support the response in DRC and neighboring countries. Fletcher stressed the importance of securing humanitarian access in areas controlled by armed groups, stating: "These are tough operating environments for lifesaving work. We face conflict and high population movement." MONUSCO, the UN peacekeeping mission, is running an air bridge and deploying vehicles to strengthen logistics in areas where road access is compromised.

UNICEF has sent an emergency response team to Bunia and deployed a water and sanitation expert to explain Ebola prevention measures to communities and schools across Ituri.

MSF: On-the-Ground Medical Response

Doctors Without Borders (MSF) has mobilized teams of medical, logistical, and support staff with experience responding to previous Ebola outbreaks. MSF is responding to alerts of suspected cases across surrounding areas, dispatching essential supplies, and setting up isolation zones at hospitals including Kyeshero Hospital in Goma, North Kivu.

MSF has emphasized that community engagement is the backbone of the response: "Vaccination, testing, treatment units, and contact tracing only work if communities have the information they need to prevent the further spread of Ebola disease." The organization has also stated its readiness to contribute to clinical research trials for experimental Bundibugyo treatments and vaccines.

Africa CDC: Continental Coordination and Risk Assessment

Africa Centers for Disease Control has established a continental Incident Management Support Team alongside WHO, and its Director Jean Kaseya has confirmed that a major vaccine research program is now underway with international partners. Africa CDC has warned that 10 additional African countries are at risk from this outbreak, and has elevated the regional risk assessment accordingly, even as the global risk to populations outside Africa remains classified as low.

Core Disease Control Measures in the Field

In the absence of vaccines or approved therapeutics, the outbreak response relies on a set of proven public health interventions that have successfully controlled previous Ebola outbreaks:

Surveillance and early case detection - Identifying cases rapidly is the first line of defense. Teams are working to expand laboratory capacity for Bundibugyo-specific testing across affected health zones, after early diagnostic failures allowed cases to go undetected.

Isolation and infection prevention - Confirmed and suspected cases are placed in dedicated treatment centers where healthcare workers use full personal protective equipment. The rapid establishment of up to 50 US-funded treatment clinics is designed to expand isolation capacity across affected areas.

Contact tracing - Every person who has had contact with a confirmed case is identified, monitored for 21 days (the maximum Ebola incubation period), and isolated at the first sign of symptoms. Ongoing insecurity and poor road networks are severely limiting the completeness of contact tracing in Ituri and North Kivu.

Safe and dignified burials - Because Ebola-infected bodies are highly contagious, safe burial teams are deployed to ensure that deceased individuals are interred in a way that prevents transmission while respecting community dignity - a balance that is central to winning community trust.

Risk communication and community engagement - Countering misinformation and building trust are recognized as critical to outbreak control. UNICEF, MSF, Mercy Corps, and local partners are running community awareness programs across schools, transport hubs, and public areas.

Border screening and cross-border preparedness - Enhanced health screening at major border crossings between DRC, Uganda, South Sudan, and other neighboring countries is being implemented to detect travelers with Ebola symptoms before they can introduce the virus to new populations.

Supportive clinical care - In treatment centers, patients receive fluid replacement, fever management, oxygen support, and close monitoring of blood and cardiac parameters to maximize survival odds in the absence of targeted treatments.

Global Risk Assessment and What Travelers Should Know

The CDC currently classifies the overall risk to the American public and to international travelers as low. Ebola does not spread through casual contact or through the air - transmission requires direct contact with the bodily fluids of a symptomatic infected person. This biological characteristic means that well-equipped healthcare systems with proper infection control protocols can prevent local spread effectively.

On May 15, 2026, CDC issued a Level 1 Travel Health Notice for Uganda and a Level 3 Travel Health Notice for DRC - the highest advisory level, recommending that travelers avoid nonessential travel to the affected regions of DRC. Enhanced screening is in place at US airports for travelers arriving from DRC and Uganda.

Anyone who has traveled to affected areas and develops fever, headache, muscle pain, vomiting, diarrhea, or unexplained bleeding within 21 days of travel should seek immediate medical care, inform their healthcare provider of their travel history before arriving at a clinical setting, and follow isolation precautions until Ebola is ruled out.

The Road Ahead: What Will Determine This Outbreak's Trajectory

Research and the Vaccine Gap

The most critical long-term need is the accelerated development and deployment of vaccines and therapeutics specifically targeting the Bundibugyo strain. The world has seen what targeted medical countermeasures can accomplish: the 2018 to 2020 DRC Kivu epidemic - the deadliest in DRC's history, with 3,470 cases and 2,287 deaths - was eventually brought under control in significant part through ring vaccination with Ervebo. Without equivalent tools for Bundibugyo, this outbreak will require sustained, resource-intensive public health efforts over a much longer timeframe.

International partners and research institutions are urgently assessing whether existing Ebola vaccines could play any role through cross-reactive immunity, and clinical trial frameworks for experimental Bundibugyo-specific candidates are being established as rapidly as possible.

Community Trust as the Determining Factor

Every expert involved in this response has identified community trust as the single most important non-medical determinant of whether this outbreak is brought under control. Historical experience with Ebola in the DRC shows that outbreaks end when communities understand the disease, accept health workers into their homes and villages, cooperate with contact tracing, and allow safe burials.

The attacks on treatment centers, the persistence of misinformation, and the deep institutional distrust rooted in decades of conflict and failed governance are the factors that most threaten to allow this outbreak to persist and expand beyond the current affected provinces.

Funding Adequacy and Aid Cuts

A critical concern raised by multiple aid organizations is that years of declining humanitarian assistance to eastern DRC have left the healthcare infrastructure weaker than it was during the 2018 to 2020 Kivu response. With fewer community health workers trained and deployed, fewer operational health centers, and reduced stockpiles of PPE and supplies, the baseline capacity to respond was lower when this outbreak began. The $60 million UN allocation and the $32 million in US bilateral assistance represent meaningful commitments - but on-the-ground workers have emphasized that sustained, adequate funding throughout the outbreak's course is what will determine whether those resources translate into effective containment.

As WFP Country Director David Stevenson put it: "This outbreak is a race against time. Without rapid, coordinated action at scale, a health crisis could quickly turn the existing food insecurity and health crisis into an uncontrollable humanitarian emergency in eastern DRC and beyond."

Conclusion: A Test of Global Health Architecture

The 2026 Ebola outbreak is, in the clearest possible terms, a test of whether the global health architecture built since the 2014 to 2016 West Africa epidemic can respond effectively to a pathogen it did not prepare for. The Bundibugyo virus exposes the most critical gap in that architecture: the assumption that the tools developed for Zaire Ebola would be sufficient for any future outbreak. They are not.

What the response is demonstrating - through the speed of the PHEIC declaration, the rapid deployment of US, UN, and NGO resources, the establishment of treatment clinics and contact tracing systems under extraordinarily difficult conditions - is that the global health system has improved its operational capacity significantly. What it is also demonstrating is that no system, however well-resourced, can function effectively in the absence of community trust, security access, and pathogen-specific medical tools.

The coming weeks will determine whether Ituri Province becomes a contained chapter in the long history of Ebola outbreaks in the DRC - or something larger. The world is watching, and the global health community is responding. Whether that response is enough depends on whether resources, security, trust, and science can converge faster than the virus spreads.

This article is for informational purposes only. If you are experiencing a medical emergency, contact local emergency services immediately. For the most current outbreak data and travel advisories, consult the WHO Ebola situation page and CDC Ebola current situation page.